Injective vs Newton Protocol — how do they compare? Injective trades at Rp94,507 (market cap Rp9,29T, Rp1,82T 24h volume), while Newton Protocol trades at Rp827.59 (market cap Rp242,66M, Rp99,81M 24h volume). The key difference: Injective is far larger — about 38284× Newton Protocol's market cap, and Newton Protocol's supply is capped (293,6M / 1B NEWT (30%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Newton Protocol for 24 Days on average.
| INJ | NEWT | |
|---|---|---|
Market Cap | Rp9,29T | Rp242,66M |
Volume (24h) | Rp1,82T | Rp99,81M |
Circulating Supply | 100M INJ | 293,6M / 1B NEWT (30%) |
Typical Hold Time | 36 Days | 24 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Newton Protocol (NEWT) is currently trading at Rp830.67 with a market cap of Rp244.07 million, showing a bearish technical signal overall. The token faces resistance near Rp856 and support at Rp834, with neutral oscillators but bearish moving averages. Recent on-chain activity indicates a 30% circulation rate and average hold time of 24 days. No major protocol upgrades or ecosystem expansions have been reported recently, keeping fundamental developments limited.
Outlook remains cautious due to bearish technicals and low liquidity. Key opportunities include potential rebounds from support levels, but risks involve high volatility, limited exchange depth, and regulatory uncertainty in the crypto space. Investors should monitor trading volume changes and broader market sentiment for directional cues.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →The Newton Protocol serves as a verifiable automation layer for on-chain finance, enabling users to delegate complex, cross-chain actions to AI agents while ensuring that each step adheres to user-DeFined guidelines through cryptographic guarantees. It combines smart accounts, such as ERC-4337 and EIP-7702, to allow for detailed delegation, along with trusted execution environment (TEE) attestations and zero-knowledge proofs (ZKPs) to verify the correctness of every off-chain decision. The ultimate aim is to transform automation into a trust-minimized framework, thereby facilitating agentic finance across multiple blockchains.
Read more on NEWT →